Your browser doesn't support javascript.
loading
Favorable response to pembrolizumab after durvalumab failure in a stage III sarcomatoid carcinoma of the lung: a case report.
Nishino, Kazumi; Kunimasa, Kei; Kimura, Madoka; Inoue, Takako; Tamiya, Motohiro; Kuhara, Hanako; Kumagai, Toru.
Afiliação
  • Nishino K; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, 541-8567, Japan. nisino-ka@mc.pref.osaka.jp.
  • Kunimasa K; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, 541-8567, Japan.
  • Kimura M; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, 541-8567, Japan.
  • Inoue T; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, 541-8567, Japan.
  • Tamiya M; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, 541-8567, Japan.
  • Kuhara H; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, 541-8567, Japan.
  • Kumagai T; Department of Thoracic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, 541-8567, Japan.
BMC Pharmacol Toxicol ; 21(1): 26, 2020 04 03.
Article em En | MEDLINE | ID: mdl-32245391

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Neoplasias Pulmonares Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Neoplasias Pulmonares Idioma: En Ano de publicação: 2020 Tipo de documento: Article